The Hepatitis C Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for Hepatitis C testing has seen considerable growth in the past few years. The market size is projected to increase from $1.24 billion in 2024 to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%.
The Hepatitis C Testing Global Market is predicted to reach $1.68 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.2%.
Download Your Free Sample of the 2025 Hepatitis C Testing Market Report and Uncover Key Trends Now!The hepatitis c testing market covered in this report is segmented –
1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests
2) By Product: Test Kits, Instruments, Reagents, Consumables
3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing
4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis
5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users
The key drivers in the hepatitis c testing marketare:
• Rising demand for early disease detection
• Increasing access to healthcare and emphasis on preventive healthcare
• Support from global health organizations and government initiatives for hepatitis C elimination
• Adoption of multiplex diagnostic platforms, AI integration in diagnostic tools, shift towards home-based testing kits, increased collaborations for test development, and the development of low-cost testing solutions.
The key trends in the hepatitis c testing market are:
• Adoption of multiplex diagnostic platforms is an emerging trend in the market.
• Integration of artificial intelligence in diagnostic tools is becoming increasingly prevalent.
• There is a shift towards home-based testing kits in the hepatitis C testing market.
• Increased collaboration for test development is a significant trend shaping the future of this market.
Major companies in the hepatitis c testing market are:
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• Hologic Inc.
• QuidelOrtho Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• SD Biosensor INC.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Cepheid
• Abcam Plc
• OraSure Technologies Inc.
• Meridian Bioscience Inc.
• Trivitron Healthcare Private Limited
• General Biologicals Corporation
• Biogate Laboratories Ltd.
• Cosara Diagnostics Private Limited
• BioGenex Life Sciences Private Limited
• BIOGENIX INC. PVT. LTD.
North America was the largest region in the hepatitis C testing market in 2024